These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Can patents deter innovation? The anticommons in biomedical research. Heller MA; Eisenberg RS Science; 1998 May; 280(5364):698-701. PubMed ID: 9563938 [TBL] [Abstract][Full Text] [Related]
26. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing. Leute K Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475 [TBL] [Abstract][Full Text] [Related]
28. Transferring innovation. Kesan JP Fordham Law Rev; 2009 Apr; 77(5):2169-223. PubMed ID: 19431909 [No Abstract] [Full Text] [Related]
29. Biobusiness on campus: commercialization of university-developed biomedical technologies. Dueker KS Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675 [No Abstract] [Full Text] [Related]
30. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception. Hoffman DC Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465 [No Abstract] [Full Text] [Related]
31. Technology Transfer: From the Research Bench to Commercialization: Part 1: Intellectual Property Rights-Basics of Patents and Copyrights. Van Norman GA; Eisenkot R JACC Basic Transl Sci; 2017 Feb; 2(1):85-97. PubMed ID: 30167556 [TBL] [Abstract][Full Text] [Related]
33. Research and the Bayh-Dole Act. Reczek PR Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412 [No Abstract] [Full Text] [Related]
34. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms. Sarpatwari A; Kesselheim AS; Cook-Deegan R J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952 [TBL] [Abstract][Full Text] [Related]
35. Is Bayh-Dole good for developing countries? Lessons from the US experience. So AD; Sampat BN; Rai AK; Cook-Deegan R; Reichman JH; Weissman R; Kapczynski A PLoS Biol; 2008 Oct; 6(10):e262. PubMed ID: 18959484 [TBL] [Abstract][Full Text] [Related]
36. Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results. Tinnemann P; Ozbay J; Saint VA; Willich SN PLoS One; 2010 Nov; 5(11):e14059. PubMed ID: 21124982 [TBL] [Abstract][Full Text] [Related]
37. Introduction to Intellectual Property: A U.S. Perspective. Murphy A; Stramiello M; Lewis S; Irving T Cold Spring Harb Perspect Med; 2015 Mar; 5(8):a020776. PubMed ID: 25818665 [TBL] [Abstract][Full Text] [Related]
38. Ethics and technology transfer: patients, patents, and public trust. Zucker D J Investig Med; 2011 Jun; 59(5):762-7. PubMed ID: 21346627 [TBL] [Abstract][Full Text] [Related]
39. In search of a compromised solution to the problem arising from patenting biomedical research tools. Derzko NM Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840 [No Abstract] [Full Text] [Related]